SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-10-030128
Filing Date
2010-12-09
Accepted
2010-12-09 18:39:17
Documents
1
Period of Report
2010-12-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3743
  Complete submission text file 0001127602-10-030128.txt   5673
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 24-1-B THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE MAIL STOP 24-1-B THOUSAND OAKS CA 91320-1799 (805)313-1762
AMGEN INC (Issuer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address AMGEN INC. ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address
Flanagan Thomas James (Reporting) CIK: 0001376155 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12477 | Film No.: 101243374